Antisense properties of tricyclo-dna

Nucleic Acids Research

Volumn 30, Issue 13, 2002, Pages 2751-2757

  Renneberg, Dorte ^a   Bouliong, Emilie ^a   Reber, Ulrich ^a   Schuümperli, Daniel ^a   Leumann, Christian J ^a  

^a Departement fur Chemie und Biochemie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; COMPLEMENTARY RNA; DNA; LIPOFECTAMINE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE DERIVATIVE; OLIGONUCLEOTIDE; PHOSPHOROTHIOIC ACID DERIVATIVE; RIBONUCLEASE H; RNA; TRICYCLODEOXYRIBONUCLEIC ACID; UNCLASSIFIED DRUG;

BINDING AFFINITY; CELL ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DNA CONFORMATION; DNA RNA HYBRIDIZATION; ENZYME SUBSTRATE; EXON; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRON; MOLECULAR STABILITY; POINT MUTATION; PRIORITY JOURNAL; REVIEW; RNA BINDING; RNA SEQUENCE; RNA SPLICING; TEMPERATURE DEPENDENCE; THERMOSTABILITY;

ALTERNATIVE SPLICING; ANIMALS; CATTLE; DNA; DNA, ANTISENSE; FETAL BLOOD; GLOBINS; HELA CELLS; HUMANS; NUCLEIC ACID CONFORMATION; NUCLEIC ACID DENATURATION; OLIGONUCLEOTIDES; RIBONUCLEASE H, CALF THYMUS; RNA, COMPLEMENTARY; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFECTION;

EID: 0036640332     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkf412     Document Type: Review

References (38)

1. Antisense oligonucleotides: A systematic high-throughout approach to target validation and gene function determination
2. Recent advances in the medicinal chemistry of antisense oligonucleotides
3. A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides
4. Novel mechanisms for antisense-mediated regulation of gene expression
5. Molecular mechanism of action of antisense drugs
6. Fluorescence microscopic comparison of the binding of phosphodiester and phosphorothioate (antisense) oligodeoxyribonucleotides to subcellular structures, including intermediate filaments, the endoplasmic reticulum, interior
7. 2′-Carbohydrate modifications in antisense oligonucleotide therapy: Importance of conformation, configuration and conjugation
8. Second generation of antisense oligonucleotides: From nuclease resistance to biological efficacy in animals
9. Antisense properties of peptide nucleic acid
10. Inhibition of gene expression inside cells by peptide nucleic acids: Effect of mRNA target sequence, mismatched bases, and PNA length
11. PNA: Synthetic polyamide nucleic acids with unusual binding properties
12. DNA analogues: From supramolecular principles to biological properties
13. Conformationally restricted carbohydrate-modified nucleic acids and antisense technology
14. Bicyclic nucleosides and conformational restriction of oligonucleotides
15. 1,5,-Anhydrohexitol oligonucleotides: Synthesis, base-pairing and recognition by regular oligodeoxyribonucleotides and oligoribonucleotides
16. Biological activity of hexitol nucleic acids targeted at Ha-ras and intracellular adhesion molecule-1 mRNA
17. LNA (locked nucleic acids): Synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition
18. Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C-methylene ribonucleosides
19. Synthesis and thermodynamic and biophysical properties of tricyclo-DNA
20. Tricyclo-DNA: A phosphodiester-backbone based DNA analog exhibiting strong complementary base-pairing properties
21. Watson-Crick base-pairing properties of tricyclo-DNA
22. Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides
23. Sensitivity of splice sites to antisense oligonucleotides in vivo
24. Double-target antisense U7 snRNAs promote efficient skipping of an aberrant exon in three human beta-thalassemic mutations
25. Morpholino antisense oligomers: The case for a RNase H-independent structural type
26. Oligdeoxyribonucleotide N3′-P5′ phosphoramidates: Synthesis and hybridization properties
27. Oligonucleotide N3′-P5′ phosphoramidates as potential therapeutic agents
28. Locked nucleic acid (LNA): Fine-tuning the recognition of DNA and RNA
29. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
30. Solution structure of a HNA-RNA hybrid
31. Hybrids of RNA and arabinonucleic acids (ANA and 2′F-ANA) are substrates of ribonuclease H
32. RNase H mediated cleavage of RNA by cyclohexene nucleic acid (CeNA)
33. Cyclohexene nucleic acids (CeNA): Serum stable oligonucleotides that activate RNase H and increase duplex stability with complementary RNA
34. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA
35. Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs
36. Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake
37. RNA interference: Listening to the sound of silence